Jun 02, 2019
Immutep Presentation at ASCO 2019
May 22, 2019
Immutep Announces European Patent Grant for Eftilagimod Alpha in Chemo-Immunotherapy
May 16, 2019
Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma
May 10, 2019
Immutep Announces Upcoming Industry Conference Participation
Apr 30, 2019
Operational Update
